Haoyuan Pharmaceuticals: Shareholder dividend return plan for the next three years.

Hao Yuan Pharmaceuticals announced that the company has developed a plan for future shareholder dividend returns over the next three years. The distribution of company profits can be in the form of cash, stocks, a combination of cash and stocks, or other methods permitted by law. For those who meet the conditions for cash dividends, cash dividends should be prioritized for profit distribution. If there are still profits available for distribution after distributing profits in cash, and the board of directors believes that issuing stock dividends is beneficial to the overall interests of all shareholders, the company can distribute profits in the form of stock dividends. If there are no major capital expenditure arrangements within the next 12 months and cash dividend conditions are met, the company should first use cash dividends for profit distribution, with an annual distribution of profits in cash not less than 15% of the distributable profits achieved in the current year's consolidated financial statements. In the mature stage of the company's development with no major capital expenditure arrangements, the proportion of cash dividends in the distribution of profits should be at least 80% in each distribution. In the mature stage with major capital expenditure arrangements, the proportion of cash dividends in the distribution of profits should be at least 40% in each distribution. In the growth stage with major capital expenditure arrangements, or in a stage where it is difficult to distinguish the development stage but with major capital expenditure arrangements, the proportion of cash dividends in the distribution of profits should be at least 20% in each distribution.